# A Phase II Study of Doxycycline in Relapsed NHL

> **NCT02086591** · PHASE2 · TERMINATED · sponsor: **University of Rochester** · enrollment: 7 (actual)

## Conditions studied

- Adult Diffuse Large B-Cell Lymphoma
- Mantle Cell Lymphoma Recurrent
- Lymphoma, Follicular
- Marginal Zone B-Cell Lymphoma
- Malignant Lymphoma - Lymphoplasmacytic
- Waldenstrom Macroglobulinemia
- Small Lymphocytic Lymphoma
- Chronic Lymphocytic Leukemia (CLL)
- T-Cell Lymphoma

## Interventions

- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT02086591
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-03
- **Primary completion:** 2015-07
- **Final completion:** 2015-11
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2016-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02086591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02086591, "A Phase II Study of Doxycycline in Relapsed NHL". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02086591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*